| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 95.39B | 95.49B | 90.57B | 83.84B | 81.49B | 69.97B |
| Gross Profit | 15.00B | 15.57B | 14.36B | 12.63B | 12.29B | 6.96B |
| EBITDA | 10.24B | 11.83B | 9.79B | 7.56B | 8.02B | 2.73B |
| Net Income | 2.44B | 3.79B | 3.85B | 1.59B | 2.79B | -1.87B |
Balance Sheet | ||||||
| Total Assets | 140.65B | 148.54B | 131.61B | 114.57B | 104.86B | 96.50B |
| Cash, Cash Equivalents and Short-Term Investments | 17.38B | 22.19B | 25.34B | 23.60B | 15.88B | 17.47B |
| Total Debt | 40.73B | 44.23B | 37.40B | 38.05B | 29.90B | 26.13B |
| Total Liabilities | 64.20B | 67.11B | 58.69B | 55.79B | 50.40B | 44.98B |
| Stockholders Equity | 74.22B | 79.11B | 70.81B | 56.85B | 52.72B | 48.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -9.21B | -6.53B | -520.00M | -3.77B | -364.00M |
| Operating Cash Flow | 0.00 | 9.06B | 9.44B | 6.25B | 2.48B | 3.42B |
| Investing Cash Flow | 0.00 | -18.75B | -14.21B | -6.60B | -6.11B | -3.19B |
| Financing Cash Flow | 0.00 | 4.70B | 5.38B | 6.91B | 1.57B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥271.89B | 16.43 | ― | 1.85% | 6.56% | 106.55% | |
75 Outperform | ¥109.52B | 36.26 | ― | 2.12% | 4.48% | -39.40% | |
74 Outperform | ¥26.91B | 11.66 | ― | 5.01% | 2.98% | -56.70% | |
68 Neutral | ¥81.06B | 14.06 | ― | 3.51% | 7.28% | 4.16% | |
67 Neutral | ¥263.24B | 16.78 | ― | 0.88% | 15.02% | 46.62% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥104.38B | 19.75 | ― | 2.27% | -0.93% | -45.03% |
CMK Corporation reported its consolidated financial results for the six months ending September 30, 2025, showing a slight increase in net sales by 2% year-on-year. However, the company faced significant declines in operating income and ordinary income, with decreases of 74.6% and 70.9% respectively, indicating challenges in maintaining profitability. The company’s equity ratio remained stable at 53.3%, and despite the financial setbacks, CMK Corporation plans to maintain its annual dividend per share at 20 yen, reflecting a commitment to shareholder returns.
The most recent analyst rating on (JP:6958) stock is a Buy with a Yen449.00 price target. To see the full list of analyst forecasts on CMK Corporation stock, see the JP:6958 Stock Forecast page.
CMK Corporation announced the recording of extraordinary income from the sale of investment securities, leading to a revision of its financial forecasts for the fiscal year ending March 31, 2026. The sale, aimed at improving asset efficiency, resulted in a gain of 1,592 million yen and has positively impacted the company’s profit forecasts and dividend payouts, reflecting a stronger financial outlook.
The most recent analyst rating on (JP:6958) stock is a Buy with a Yen449.00 price target. To see the full list of analyst forecasts on CMK Corporation stock, see the JP:6958 Stock Forecast page.
CMK Corporation has announced a merger with its wholly owned subsidiary, CMK PRODUCTS Corporation, effective April 1, 2026. This strategic move is aimed at enhancing the company’s overall strength, improving business competitiveness, and increasing management efficiency by combining mass production capabilities with short delivery prototype expertise.
The most recent analyst rating on (JP:6958) stock is a Buy with a Yen395.00 price target. To see the full list of analyst forecasts on CMK Corporation stock, see the JP:6958 Stock Forecast page.
CMK Corporation has successfully completed the payment process for issuing new shares as restricted stock compensation, a move initially announced on July 18, 2025. This issuance involves 41,624 common shares at a price of 339 yen per share, totaling 14,110,536 yen, and is allocated to six company directors, excluding outside directors, which may enhance executive alignment with shareholder interests.